Paladin Labs
Livio Di Francesco has extensive work experience in various finance and management roles. Livio started their career as an External Auditor at PwC in 1989 and then worked as a Senior Cost Accountant at Burroughs Wellcome from 1992 to 1995. In 1995, they became a Cost Accounting Supervisor at Bombardier Aerospace until 1997 when they joined Oracle as a Principal Consultant. From 1998 to 2001, they worked as a Plant Controller at Siemens Canada and then became a Regional Controller at Tyco Fire Protection from 2001 to 2003. Di Francesco then joined Valeant Pharmaceuticals as a Vice President of Finance, where they worked from 2004 to 2013. After that, they worked as the Director of Finance at Rheinmetall Canada Inc. from 2014 to 2015. Currently, Di Francesco holds the position of Vice President & General Manager at Paladin Labs since 2016.
Livio Di Francesco earned a Bachelor of Commerce (B.Com.) degree in Accounting and Finance from Concordia University from 1983 to 1987. Livio also obtained a Certified Management Accountant certification from the Ordre of CMA du Québec from 1990 to 1992. In addition, they have completed certifications in Advanced Financial Modeling and The 7 Habits of Highly Effective People from the American Management Association in 2012.
This person is not in any offices
Paladin Labs
Paladin Labs Inc., headquartered in Montreal, Canada, is a specialty pharmaceutical company focused on acquiring or in-licensing innovative pharmaceutical products for the Canadian market. Paladin has a focused marketing and sales organization that has helped it evolve into a well-known Canadian specialty pharmaceutical company with a breadth of products. Paladin is an operating company of Endo International plc (NASDAQ: ENDP), a highly focused generics and specialty branded pharmaceutical company delivering quality medicines to patients through excellence in development, manufacturing and commercialization.